The impact of SERPINE1 deficiency on cardiovascular health in older adults
Heterozygous SERPINE1 Deficiency Confers Durable Cardiovascular Fitness in Humans
This study is looking at how a change in a specific gene might help older adults stay heart-healthy as they age, and it’s for anyone interested in understanding how genetics can affect heart health in seniors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11002317 on NIH RePORTER |
What this research studies
This research investigates how a deficiency in the SERPINE1 gene affects cardiovascular fitness in older adults. By examining a unique community with a natural mutation in this gene, the study aims to understand the relationship between SERPINE1 deficiency and reduced aging-related cardiovascular issues. The approach includes analyzing health data and biological samples from participants to identify potential protective mechanisms against age-related diseases. The findings could lead to new insights into improving cardiovascular health in the aging population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 and older, particularly those with cardiovascular concerns or related health issues.
Not a fit: Patients under the age of 65 or those without cardiovascular risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing cardiovascular health and longevity in older adults.
How similar studies have performed: Previous research has shown promising results regarding the protective effects of SERPINE1 deficiency in animal models, suggesting potential for similar outcomes in humans.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Vaughan, Douglas E — Northwestern University at Chicago
- Study coordinator: Vaughan, Douglas E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.